What is the dosage of Cuvitru?

Cuvitru is available in 5 dosages, including 200 mg/ml Injection 10 ml, 200 mg/ml Injection 20 ml, 200 mg/ml Injection 40 ml, 200 mg/ml Injection 5 ml and 200 mg/ml Injection 50 ml

What does Cuvitru treat?

Cuvitru treats Immunologic Deficiency Syndromes

What is Cuvitru made of?

Cuvitru contains immunoglobulin G which is a Human Immunoglobulin G

How is Cuvitru administered?

Cuvitru is administered as a Injectable

What is Cuvitru mechanism of action?

Cuvitru mechanism of action is Antigen Neutralization

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Cuvitru

(immunoglobulin G)

10 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]20 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]

View 3 more

BLACK BOX WARNING

Dosage & administration

For subcutaneous infusion only.

Administer at regular intervals from daily up to every two weeks (biweekly).

Individualize dose based on the patient's pharmacokinetic and clinical response.

Monitor serum IgG trough levels regularly to guide subsequent dose adjustments and dosing intervals as needed.

Switching from Immune Globulin Intravenous (Human) treatment (IGIV) or adult patients switching from HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]:

* Begin treatment one week after the patient's last IGIV or HYQVIA infusion.
* Establish initial weekly dose by converting the monthly IGIV or HYQVIA dose into equivalent weekly dose and increasing it using a dose adjustment factor.

Initial Weekly dose =	Previous IGIVor HYQVIA dose (in grams) × 1.30
	No. of weeks between IGIVor HYQVIA doses.

* Frequent dosing (2-7 times per week): Divide the calculated weekly dose by the desired number of times per week.
* Biweekly dosing: Multiply the calculated weekly dose by 2.
Switching from Immune Globulin Subcutaneous (Human) treatment (IGSC):
* Weekly dose (in grams) should be the same as the weekly dose of prior IGSC treatment (in grams).
* Frequent dosing (2-7 times per week): Divide the calculated weekly dose by the desired number of times per week.
* Biweekly dosing: Multiply the calculated weekly dose by 2.
Infusion sites: up to 4 infusion sites simultaneously, with at least 4 inches between sites avoiding bony prominences. Rotate sites with each administration.

drug label

Cuvitru prescribing information

Have more Cuvitru questions?

Submit MSL Request

Learn More

Need to report a Cuvitru issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Cuvitru Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

Cuvitru One Path Start Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Cuvitru Financial assistance options

Co-pay savings program

commercial only

Cuvitru One Path Start Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement